Get started
Author

W A Meyer-Sabellek

Observed names: Meyer-Sabellek, W MEYERSABELLEK, W MEYER‐SABELLEK, W Meyer-Sabellek, W. A. Meyer-Sabellek, W. MEYER‐SABELLEK, W. Meyer-Saballek, W. Meyer-Sabellek, W. Meyer‐Sabellek, WOLFGANG MEYER-SABELLEK, Wolfgang Meyer-Sabellek, Wolfgang Meyer‐Sabellek
Observed institutions: University of Southern California, University of Nottingham, Universität Hamburg, Bayreuth Medical Center, Rigshospitalet, Humboldt-Universität zu Berlin, Diakonie Klinikum Jung-Stilling, Silence Therapeutics (Germany), Deutsches Herzzentrum der Charité, University Hospital Frankfurt, AstraZeneca (Sweden), Klinikum Fulda, AstraZeneca (Germany), Freie Universität Berlin, Charité – Universitätsmedizin Berlin, Otto-von-Guericke-Universität Magdeburg
OpenAlex ID: A5111709536
Extent of early ST segment elevation resolution: A strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens
1995 · Rolf Schröder, Karl Wegscheider, et al. · Journal of the American College of Cardiology · 361
PDF
Prevalence of extra‐oesophageal manifestations in gastro‐oesophageal reflux disease: an analysis based on the ProGERD Study
2003 · D. Jaspersen, M. Kulig, et al. · Alimentary Pharmacology & Therapeutics · 286
PDF
Quality of life in relation to symptoms in patients with gastro‐oesophageal reflux disease — an analysis based on the ProGERD initiative
2003 · M. Kulig, A. Leodolter, et al. · Alimentary Pharmacology & Therapeutics · 249
PDF
Risk Factors for Erosive Esophagitis: A Multivariate Analysis Based on the ProGERD Study Initiative
2004 · Joachim Labenz, Daniel Jaspersen, et al. · The American Journal of Gastroenterology · 187
A meta‐analysis comparing eradication, healing and relapse rates in patients with Helicobacter pylori‐associated gastric or duodenal ulcer
2001 · A. Leodolter, M. Kulig, et al. · Alimentary Pharmacology & Therapeutics · 158
PDF
Prospective Follow-Up Data from the ProGERD Study Suggest that GERD Is Not a Categorial Disease
2006 · Joachim Labenz, Marc Nocon, et al. · The American Journal of Gastroenterology · 157
Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD study
2004 · M Kulig, M Nocon, et al. · Journal of Clinical Epidemiology · 156
Association of body mass index with heartburn, regurgitation and esophagitis: Results of the Progression of Gastroesophageal Reflux Disease study
2006 · Marc Nocon, Joachim Labenz, et al. · Journal of Gastroenterology and Hepatology · 102
Abnormal Bone Histology in Idiopathic Hypercalciuria *
1980 · HARTMUT H. MALLUCHE, WOLFGANG TSCHOEPE, et al. · The Journal of Clinical Endocrinology & Metabolism · 97
Dose finding with a novel recombinant plasminogen activator (BM 06,022) in patients with acute myocardial infarction: Results of the German recombinant plasminogen activator study
1994 · Karl-Ludwig Neuhaus, Rainer von Essen, et al. · Journal of the American College of Cardiology · 61
PDF
Alkaline phosphatase
1988 · Wolfgang Meyer-Sabellek, Pranav Sinha, et al. · Journal of Chromatography B Biomedical Sciences and Applications · 60
What Parameters Are Relevant for the Histological Diagnosis of Gastroesophageal Reflux Disease without Barrett’s Mucosa?
2004 · M. Vieth, U. Peitz, et al. · Digestive Diseases · 57
Open, noncontrolled dose-finding study with a novel recombinant plasminogen activator (BM 06.022) given as a double bolus in patients with acute myocardial infarction
1993 · Ulrich Tebbe, Rainer von Essen, et al. · The American Journal of Cardiology · 51
Antihypertensive and metabolic effects of diltiazem and nifedipine.
1986 · K L Schulte, W A Meyer-Sabellek, et al. · Hypertension · 51
PDF
Cost‐of‐disease analysis in patients with gastro‐oesophageal reflux disease and Barrett's mucosa
2006 · S. N. WILLICH, M. NOCON, et al. · Alimentary Pharmacology & Therapeutics · 50
Inhaled pan-selectin antagonist Bimosiamose attenuates airway inflammation in COPD
2012 · Henrik Watz, Daniel Bock, et al. · Pulmonary Pharmacology & Therapeutics · 47
The effect of adjustable dosing with budesonide/formoterol on health-related quality of life and asthma control compared with fixed dosing
2004 · R. Buhl, P. Kardos, et al. · Current Medical Research and Opinion · 41
Long-term clinical course of extra-oesophageal manifestations in patients with gastro-oesophageal reflux disease
2006 · D. Jaspersen, J. Labenz, et al. · Digestive and Liver Disease · 39
Is patient self-report an adequate tool for monitoring cardiovascular conditions in patients with hypercholesterolemia?
2010 · H. Englert, J. Muller-Nordhorn, et al. · Journal of Public Health · 38
Relation of regression of left ventricular hypertrophy to changes in ambulatory blood pressure after long-term therapy with perindopril versus nifedipine
1992 · Karl-Ludwig Schulte, Wolfgang Meyer-Sabellek, et al. · The American Journal of Cardiology · 34
Histological effects of esomeprazole therapy on the squamous epithelium of the distal oesophagus
2005 · M. VIETH, M. KULIG, et al. · Alimentary Pharmacology & Therapeutics · 32
PDF
Statistical analysis of circadian blood pressure recordings in controlled clinical trials.
1989 · B Streitberg, W Meyer-Sabellek, et al. · PubMed · 32
Functional versus structural changes of forearm vascular resistance in hypertension.
1988 · K L Schulte, J Braun, et al. · Hypertension · 32
Resolution of alkaline phosphatase isoenzymes in serum by isoelectric focusing in immobilized pH gradients.
1986 · P K Sinha, A Bianchi-Bosisio, et al. · Clinical Chemistry · 32
Off-Label-Use
2003 · A. Tolle, W. Meyer-Sabellek · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · 31
Works count: 140
Citation count: 3,062
H-index: 27
I10-index: 51
Year
Topic
Type